181 related articles for article (PubMed ID: 23002278)
1. Risk factors for local and regional recurrence in patients with resected N0-N1 non-small-cell lung cancer, with implications for patient selection for adjuvant radiation therapy.
Lopez Guerra JL; Gomez DR; Lin SH; Levy LB; Zhuang Y; Komaki R; Jaen J; Vaporciyan AA; Swisher SG; Cox JD; Liao Z; Rice DC
Ann Oncol; 2013 Jan; 24(1):67-74. PubMed ID: 23002278
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for locoregional recurrence in patients with resected N1 non-small cell lung cancer: a retrospective study to identify patterns of failure and implications for adjuvant radiotherapy.
Fan C; Gao S; Hui Z; Liang J; Lv J; Wang X; He J; Wang L
Radiat Oncol; 2013 Dec; 8():286. PubMed ID: 24321392
[TBL] [Abstract][Full Text] [Related]
3. Nodal stage of surgically resected non-small cell lung cancer and its effect on recurrence patterns and overall survival.
Varlotto JM; Yao AN; DeCamp MM; Ramakrishna S; Recht A; Flickinger J; Andrei A; Reed MF; Toth JW; Fizgerald TJ; Higgins K; Zheng X; Shelkey J; Medford-Davis LN; Belani C; Kelsey CR
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):765-73. PubMed ID: 25752390
[TBL] [Abstract][Full Text] [Related]
4. Completely resected N1 non-small cell lung cancer: factors affecting recurrence and long-term survival.
Fujimoto T; Cassivi SD; Yang P; Barnes SA; Nichols FC; Deschamps C; Allen MS; Pairolero PC
J Thorac Cardiovasc Surg; 2006 Sep; 132(3):499-506. PubMed ID: 16935101
[TBL] [Abstract][Full Text] [Related]
5. Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence.
Harpole DH; Herndon JE; Young WG; Wolfe WG; Sabiston DC
Cancer; 1995 Sep; 76(5):787-96. PubMed ID: 8625181
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of lymphovascular invasion compared with that of visceral pleural invasion in patients with pN0 non-small-cell lung cancer and a tumor diameter of 2 cm or smaller.
Tao H; Hayashi T; Sano F; Takahagi A; Tanaka T; Matsuda E; Okabe K
J Surg Res; 2013 Nov; 185(1):250-4. PubMed ID: 23830361
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for local recurrence after lobectomy and lymph node dissection in patients with non-small cell lung cancer: Implications for adjuvant therapy.
Isaka M; Kojima H; Takahashi S; Omae K; Ohde Y
Lung Cancer; 2018 Jan; 115():28-33. PubMed ID: 29290258
[TBL] [Abstract][Full Text] [Related]
8. Risk Factors for Local and Distant Recurrence After Surgical Treatment in Patients With Non-Small-Cell Lung Cancer.
Dziedzic DA; Rudzinski P; Langfort R; Orlowski T;
Clin Lung Cancer; 2016 Sep; 17(5):e157-e167. PubMed ID: 26831834
[TBL] [Abstract][Full Text] [Related]
9. Local failure in resected N1 lung cancer: implications for adjuvant therapy.
Higgins KA; Chino JP; Berry M; Ready N; Boyd J; Yoo DS; Kelsey CR
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):727-33. PubMed ID: 22208965
[TBL] [Abstract][Full Text] [Related]
10. The prognostic factors of resected non-small cell lung cancer with chest wall invasion.
Lee CY; Byun CS; Lee JG; Kim DJ; Cho BC; Chung KY; Park IK
World J Surg Oncol; 2012 Jan; 10():9. PubMed ID: 22236955
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact and initial recurrence site of lymphovascular and visceral pleural invasion in surgically resected stage I non-small-cell lung carcinoma.
Yanagawa N; Shiono S; Abiko M; Ogata SY; Sato T; Tamura G
Eur J Cardiothorac Surg; 2013 Sep; 44(3):e200-6. PubMed ID: 23766428
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for tumor recurrence in patients with early-stage (stage I and II) non-small cell lung cancer: patient selection criteria for adjuvant chemotherapy according to the seventh edition TNM classification.
Maeda R; Yoshida J; Ishii G; Hishida T; Nishimura M; Nagai K
Chest; 2011 Dec; 140(6):1494-1502. PubMed ID: 21622548
[TBL] [Abstract][Full Text] [Related]
13. Prognosis After Sublobar Resection of Small-sized Non-small Cell Lung Cancer with Visceral Pleural or Lymphovascular Invasion.
Moon Y; Lee KY; Park JK
World J Surg; 2017 Nov; 41(11):2769-2777. PubMed ID: 28597091
[TBL] [Abstract][Full Text] [Related]
14. Lymphovascular invasion in non-small-cell lung cancer: implications for staging and adjuvant therapy.
Higgins KA; Chino JP; Ready N; D'Amico TA; Berry MF; Sporn T; Boyd J; Kelsey CR
J Thorac Oncol; 2012 Jul; 7(7):1141-7. PubMed ID: 22617241
[TBL] [Abstract][Full Text] [Related]
15. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
[TBL] [Abstract][Full Text] [Related]
16. Sublobar Resection in Stage IA Non-Small Cell Lung Cancer: Role of Preoperative CT Features in Predicting Pathologic Lymphovascular Invasion and Postoperative Recurrence.
Choe J; Kim MY; Yun JK; Lee GD; Kim YH; Choi S; Kim DK
AJR Am J Roentgenol; 2021 Oct; 217(4):871-881. PubMed ID: 33978462
[No Abstract] [Full Text] [Related]
17. Risk factors for recurrence in patients with resected N1 non-small cell lung cancer - a systematic review and meta-analysis.
Luo H; Qiao L; Liang N; Zhang J
J BUON; 2015; 20(3):791-9. PubMed ID: 26214632
[TBL] [Abstract][Full Text] [Related]
18. The impact of surgical adjuvant thoracic radiation therapy for patients with nonsmall cell lung carcinoma with ipsilateral mediastinal lymph node involvement.
Sawyer TE; Bonner JA; Gould PM; Foote RL; Deschamps C; Trastek VF; Pairolero PC; Allen MS; Shaw EG; Marks RS; Frytak S; Lange CM; Li H
Cancer; 1997 Oct; 80(8):1399-408. PubMed ID: 9338463
[TBL] [Abstract][Full Text] [Related]
19. Patterns of failure and overall survival in patients with completely resected T3 N0 M0 non-small cell lung cancer.
Gould PM; Bonner JA; Sawyer TE; Deschamps C; Lange CM; Li H
Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):91-5. PubMed ID: 10477011
[TBL] [Abstract][Full Text] [Related]
20. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
